Passive immunization of tilapia, Oreochromis niloticus, was conducted to determine whether anti-Streptococcus iniae whole sera (ASI), heat inactivated anti-S. iniae whole sera (HIASI) and normal whole sera (NWS) were protective when intraperitoneally (i.p.) injected into tilapia. The ASI was produced in tilapia actively immunized (challenged) with virulent S. iniae by i.p. injection. An antibody response against S. iniae was demonstrated by enzyme linked immunosorbent assay (ELISA) and 18% of the immunized ®sh died because of the S. iniae infection. The actively immunized tilapia demonstrated a secondary antibody response and immunity to S. iniae after challenge with S. iniae by i.p. injection. Survival was 100% in the actively immunized ®sh. The NWS was obtained from tilapia free of ASI antibody and susceptible to S. iniae infection (40% mortality). In two separate experiments, signi®cantly higher mortality was noted in tilapia passively immunized with NWS (33 and 53%) and phosphate buffered saline (PBS) (30 and 60%), in comparison with mortalities of 0 and 10% or 3.3 and 6.7% in the ®sh passively immunized with ASI or HIASI 14 days after S. iniae infection by i.p. injection (P 0.0003 and 0.0023). Results suggest that immunity provided by ASI and HIASI was because of antibody against S. iniae. Inactivation of complement in the HIASI treatment further suggests that ASI antibody plays a primary role in immunity against S. iniae infection.
Introduction
Streptococcal disease caused by Streptococcus iniae is responsible for signi®cant economic losses to the world aquaculture industry, especially the production of warm water species such as tilapia (Perera, Collins, Johnson & Lewis 1994; Perera, Johnson & Lewis 1997; Shoemaker & Klesius 1997; Muzquiz, Royo, Ortega, De Blias, Ruiz & Alonso 1999) . Because of the ineffectiveness of antibiotic treatment, the need for a vaccine against S. iniae is paramount in the control of streptococcal disease . Recently, we reported the ef®cacy of a killed S. iniae vaccine in tilapia (Klesius, Shoemaker & Evans 1999 . Signi®cant anti-Streptococcus iniae (ASI) responses were observed in the immunized tilapia , however, their role in immunity as demonstrated by active immunization was not determined. Further, ASI responses have been demonstrated in S. iniae challenged tilapia , but again, their role in immunity was not determined after infection. A recently developed immunoassay for ASI in tilapia serum (Shelby, Shoemaker, Evans & Klesius 2001 ) provided a method to investigate the role of ASI in immunity against S. iniae in tilapia.
Experimental passive immunization has been attempted with varying results in ®sh species. Klesius & Sealey (1995) were unable to reduce mortality of cat®sh to Edwardsiella ictaluri using sera of ®sh which had survived infection, although antibody titres were signi®cantly elevated in passively immunized animals. Akhlaghi, Munday & Whittington (1996) were able to reduce mortalities in rainbow trout due to streptococcal infection by passive immunization with sheep and rabbit antibodies. However, mortalities were not reduced after passive immunization with rainbow trout antibodies against Streptococcus sp. In a later experiment, Akhlaghi (1999) was able to demonstrate reduced mortality in rainbow trout due to vibriosis using passive immunization with sheep, rabbit and trout antibodies. From these studies on passive immunization with whole sera from immune and normal ®sh, it was shown that the role of antibody in immunity against ®sh pathogens can be determined. Thus, the objective of this study was to determine the role of ASI antibody in immunity against S. iniae using passive immunization and enzyme linked immunosorbent assay (ELISA) methods.
Materials and methods

Bacterium
Streptococcus iniae isolate ARS-60 was grown in tryptic soy broth (TSB) (Difco Laboratories, Sparks, MD, USA) for 24 h at 27°C. The cultures were adjusted to 2.5´10 7 colony forming units (cfu) mL ±1 and 5.0´10 7 cfu mL ±1 for the immunization and challenge inocula, respectively. Fish were immunized or challenged by intraperitoneal (i.p.) injection of 100 lL of each inoculum.
Fish
The tilapia, Oreochromis niloticus (L.), were from stocks maintained at the ARS, USDA Aquatic Animal Health Research Laboratory (Auburn, AL, USA). Prior to experimentation, a sample of tilapia was determined to be culture and ELISA-negative for S. iniae or S. iniae antibody. Tilapia were acclimatized in¯ow-through 57-L glass aquaria supplied with 0.5 L h ±1 dechlorinated water for 10 days prior to experiments. Fish were fed daily to satiation with Aquamax Grower 400 (PMI Nutrition International, Brentwood, MO, USA). A light and dark period of 12:12 h was maintained and aeration was supplied by air stones.
Water quality
The dissolved oxygen, temperature and salinity were measured daily using a YSI 85 oxygen conductivity, salinity and temperature meter (Yellow Spring Instrument, Yellow Springs, OH, USA). The pH, hardness, ammonia and nitrites were determined daily using a Fresh Water Aquaculture Kit Model AG-2 (LaMotte, Chestertown, MD, USA). The water quality parameters (mean SD) were 6.02 0.561 mg L ±1 dissolved oxygen, 27.4 0.63°C, 7.2 0.1 pH, 0.1 0.0% salinity, 110.0 10.0 mg L ±1 hardness and 0 mg L ±1 ammonia and nitrite concentrations.
Active immunization
Six replicate aquaria of 20 ®sh (mean weight 71 10 g) each were used in the generation of serum (blood collection is described in detail in the ELISA section). Tilapia in three replicate aquaria were immunized with virulent S. iniae and were the source of ASI whole sera obtained from the caudal vein of ®sh at 28 days post-injection (DPI). Tilapia in the three remaining aquaria were injected with 100 lL of sterile TSB and were the source of the normal whole sera (NWS). In addition, at weekly intervals, random serum samples were obtained from three ®sh per aquaria (non-lethal bleeding) of the immunized and control tilapia. The immunized and non-immunized ®sh were monitored daily for mortality and disease signs. On 29 DPI, surviving tilapia were challenged with S. iniae by i.p. injection. The ®sh were monitored as above for an additional period of 20 DPI.
Passive immunization with ASI, HIASI and NWS
In the ®rst passive immunization experiment, 12 replicate aquaria of 13 ®sh (mean weight of 16.6 5 g) each were used. Tilapia in three replicate aquaria were passively immunized with 100 lL of either ASI, heat inactivated anti-S. iniae whole sera (HIASI), NWS or phosphate buffered saline (PBS). The HIASI was generated by heat inactivating the ASI for 1 h at 56°C (Drevets & Campbell 1991) . Additionally, tilapia in three replicate aquaria were injected with PBS and not challenged with S. iniae. After randomly removing and bleeding three tilapia from each aquaria 2 days after passive immunization, the ®sh receiving either ASI, HIASI, NWS or PBS were challenged with S. iniae. All ®sh were monitored daily for mortality and disease signs for a period of 14 DPI. Dead ®sh were cultured to con®rm S. iniae. Serum samples were taken from the surviving ®sh at this time for ASI antibody assay by ELISA. This experiment was repeated with smaller ®sh (mean weight 3.62 0.5 g), however, no serum samples were taken and no ASI antibody was measured.
ELISA
Fish were bled from the caudual vein and the blood allowed to clot for 1 h at 25°C. Serum was separated after centrifugation at 300 g and stored at ±80°C. Sera of the ®sh were tested individually for ASI antibody response by indirect ELISA (Shelby et al. 2001) . The streptococcal antigen was prepared by sonication (Model 150, Artek Systems Corp., Farmingdale, NY, USA) of whole packed S. iniae ARS-60 cells (5-day culture, harvested by centrifugation at 4000 g) at full power for 1 min. The resulting sonicate was centrifuged at 4000 g and the supernatant removed from the cellular debris by pipette. The total protein of the sonicate supernatant (streptococcal antigen) was determined by the bicinchoninic acid (BCA) method (Pierce 23235X, Rockford, IL, USA) and adjusted to a protein concentration of 500 lg mL ±1 using 0.05 m sodium carbonate buffer (pH 9.6). One hundred lL of streptococcal antigen was added to each well of a microtitre plate (Falcon 3915, Becton Dickinson, Lincoln Park, NJ, USA) and the plate incubated for 1 h at 25°C. The wells were blocked with 3% bovine serum albumin (Sigma A-7030; St. Louis, MO, USA) for 1 h at 25°C and then the wells were washed ®ve times with PBS plus 0.05% tween-20 (PBS-T).
One hundred lL of a serum sample (1 lL of serum diluted in 999 lL of PBS-T) was added to four replicate wells of the plate. The plate was incubated for 30 min at 25°C. The wells of the plate were washed three times with PBS-T, 100 lL of goat anti-tilapia immunoglobulin serum (Shelby et al. 2001 ) (diluted 1:5000 in PBS-T) was added, and the plate was then incubated for 30 min at 25°C. After washing again, 100 lL of rabbit antigoat peroxidase conjugate (Sigma A-5420), diluted 1:5000 in PBS-T, was added. The wells of the plate were again washed and 100 lL of o-phenylenediamine in urea-peroxide buffer (Sigma P-9187) was added to each well. The ELISA reaction was stopped at 15 min, with 50 lL of 3 m H 2 SO 4 , and optical density (OD) of the reactions read spectrophotometrically at 490 nm. Negative controls consisted of wells coated with antigen and no serum sample, and wells with no antigen and a serum sample. The control reactions gave an OD of 0.04 or less.
Statistical analysis
Statistical differences between mortality and ELISA values were analysed by SAS (SAS Institute Inc. 1997) with one-way analysis of variance using Duncan's multiple range test for signi®cance. Signi®cant differences were determined at P < 0.05.
Results
Active immunization with virulent S. iniae
Four days after injection with S. iniae, disease signs became apparent in the actively immunized ®sh. The signs observed included erratic swimming, lethargy, darkening of skin pigment, eye opacity, body curvature and no or slow acceptance of food. The cumulative mortality was 18% at 28 DPI in the immunized ®sh. After challenge injection with S. iniae, no additional mortalities were observed in the immunized ®sh. A cumulative mortality of 40% was observed in the non-immunized ®sh. The daily cumulative mortalities are shown in Fig. 1 . Disease signs were absent in the actively immunized ®sh following the second infection and survival was 100%.
The ASI antibody response after active immunization and challenge is shown in Fig. 2 . Active immunization resulted in a primary antibody response that was initiated at 7 DPI and peaked at 14 DPI. Challenge resulted in signi®cantly increased secondary response at 14 and 21 DPI. The non-immunized ®sh showed a signi®cantly increased primary antibody response after challenge. The secondary ASI antibody response coincided with 100% survival, providing a direct measure of immunity in the immunized ®sh.
Passive immunization with ASI, HIASI and NWS
The percent cumulative mortalities of tilapia after passive immunization with ASI, HIASI, NWS and PBS (control) in the ®rst immunization experiment Journal of Fish Diseases 2002, 25, 1±6 are shown in Fig. 3 . Mean percent cumulative mortalities ( SEM) were 0.0, 3.3 ( 3.3), 33.3 ( 3.3) and 30.0 ( 5.8)%, respectively. Disease signs were noted in the ®sh passively immunized with NWS and PBS, but not in the ®sh receiving ASI. The one ®sh that died in the HIASI treatment showed signs of streptococcal disease (cloudy eyes and serpentine swimming; Evans et al. 2000) . The mortality of the ®sh immunized with ASI and HIASI was 0.0 and 3.3%, respectively, and was signi®cantly lower (P 0.0003) than the mortality in the NWS or PBS treatments (33.3 and 30.0%, respectively). Signi®cant differences (P 0.001) in ASI antibody titres measured by ELISA were seen between ®sh which received immune serum ASI (0.101 0.001 OD) or HIASI (0.103 0.006 OD), and those which received NWS or PBS (0.052 0.001 and 0.056 0.00 OD, respectively), 48 h following immunization. No ASI antibody was detected in NWS or PBS immunized ®sh at 48 h. After challenge, ASI antibody titres increased to 0.11 0.007 and 0.098 0.015 OD in the ®sh passively immunized with NWS and PBS, respectively. The ASI or HIASI passively immunized ®sh had no such increase in their antibody titre (0.09 0.006 or 0.08 0.002 OD). Control ®sh injected with PBS, and not challenged, had neither ASI antibody titre nor mortality. Figure 1 Percentage of cumulative mortality in the actively immunized (,) and non-immunized (s) tilapia for 28 DPI after S. iniae challenge. Fish actively immunized were i.p. injected with 100 lL of 2.5´10 7 cfu mL ±1 of S. iniae. Non-immunized ®sh were i.p. injected with 100 lL of TSB. The actively immunized and non-immunized ®sh were challenged (®) with 5.0´10 7 cfu mL ±1 of S. iniae by i.p. injection at 29 DPI and monitored for an additional 20 DPI after S. iniae challenge. Figure 2 Anti-S. iniae antibody (ELISA OD) response in actively immunized (,) and non-immunized tilapia (s) for 28 DPI after S. iniae challenge. Fish actively immunized were i.p. injected with 100 lL of 2.5´10 7 cfu mL ±1 of S. iniae. Nonimmunized ®sh were i.p. injected with 100 lL of TSB. The actively immunized and non-immunized ®sh were challenged (®) with 5.0´10 7 cfu mL ±1 of S. iniae by i.p. injection at 29 DPI and monitored for an additional 21 DPI after S. iniae challenge. Results of the second passive immunization experiment are shown in Fig. 4 . Mean percentage cumulative mortalities ( SEM) were 10.0 ( 0.0), 6.7 ( 6.7), 53.3 ( 8.8) and 60.0 ( 11.5)%, for ASI, HIASI, NWS and PBS treatments, respectively. Statistical signi®cance was similar to that of the ®rst experiment (P 0.0023). As in the ®rst experiment, disease signs were observed only in the ®sh treated with NWS and PBS. The mortalities in the ASI and HIASI treatments were not accompanied by disease signs and S. iniae was not recovered from these animals.
Discussion
In the present study, tilapia responded with a primary and secondary ASI antibody response after active immunization and challenge with virulent S. iniae. The secondary response was signi®cantly higher than the primary antibody response and coincided with immunity to S. iniae. This observation was supported by positive results of the ASI and HIASI-passive immunization which provided immunity against S. iniae. The greater effectiveness of passive immunization in the second experiment can be attributed to the smaller size of the animals which translated into a relatively larger amount of challenge inoculum. Muzquiz et al. (1999) reported similar results in trout following challenge with Lactococcus garvieae, where smaller trout were more susceptible to disease. Following challenge of ASI and HIASI with S. iniae, no increased antibody response was seen. This suggests that the ASI antibody which was passively transferred caused an immediate immunity to the challenge infection in these ®sh. Low levels of circulating speci®c antibody detected in the passively immunized ®sh were not surprising considering the dilution in blood at 48 h as a result of the i.p. route of passive immunization. The protective antibody may act in conjunction with complement in vivo in a direct bactericidal response or aid phagocytes in their ability to engulf and kill S. iniae. Immunity against Group-B streptococcal infection was shown to be dependent on a speci®c streptococcal antibody dependent phagocytic response by polymorphonuclear cells (Klesius, Zimmerman, Mathews & Krushak 1974; . The lack of immunity after passive immunization with NWS indicates that antibody may be solely responsible for protective immunity, rather than immunity mediated by nonspeci®c serum components of NWS. Further, heat inactivation (in vitro) of ASI resulted in no difference in survival of tilapia immunized with HIASI. These results suggest that complement or cytokines in the passively immunized serum are not responsible for protection, further de®ning the role of ASI antibody in protective immunity to streptococcal disease.
Previously, Eldar, Horovitz & Bercovier (1997) showed that passive immunization of S. iniae antibody that was produced in ®sh immunized with killed S. iniae vaccine imparted protection in rainbow trout. A mortality rate of 40% was reported in trout immunized with the hyperimmune trout serum as compared with a mortality rate of 73.3% in the saline injected ®sh. Based on these results, they concluded that antibody alone was not responsible for protective immunity by hyperimmune serum. Akhlaghi et al. (1996) compared the results of passive and active immunization of rainbow trout against Streptococcus sp. The mortality of ®sh passively immunized with sheep, rabbit and trout hyperimmune sera were 8.3, 37.5 and 75% after 1 month. We observed cumulative mortality of 0 and 3.3% in passively immunized tilapia. Trout actively immunized with killed streptococcal cells had a survival of 91.7% after 1 month (Akhlaghi et al. 1996) . In the present study, there was 100% survival in the actively immunized tilapia. This difference may re¯ect the formulation of the vaccines, i.e. live vs. killed. Akhlaghi et al. (1996) reported that anti-streptococcal antibody titres were detected only in trout passively immunized with the sheep and rabbit hyperimmune sera at 24 h by ELISA. Active immunization also produced an anti-streptococcal antibody response. These authors concluded that protective immunity was caused by speci®c antibody against the Streptococcus sp. in trout, but the level of antibody needed for immunity was not determined.
Very low titres of humoral ASI antibody (1:1±1:30 serum dilutions) were found by an agglutination test in trout immunized with killed vaccine (Eldar et al. 1997) . The kinetics of the ASI responses were not determined in either S. iniae immunized and challenged or non-immunized and challenged trout in their experiments. The use of an ELISA is a more sensitive and speci®c assay than an agglutination assay to measure an antibody response against S. iniae after active immunization or infection. Further, elevated ASI antibody levels are strongly predictive of immunity against S. iniae. The exact ASI antibody range of protective titres is yet to be determined, but an ELISA OD of 0.1 or greater is mostly likely re¯ective of protection using a 1:1000 dilution of serum.
In summary, our results show that S. iniae infection stimulates antibodies against S. iniae and that these antibodies do protect against experimental S. iniae infection; thus, this indicates that ASI antibody plays a primary role in immunity to S. iniae. Future experiments are underway to determine whether ASI antibody stimulated by immunization with killed S. iniae vaccine (Klesius et al. 1999 provides immunity to S. iniae and to elucidate the titre range of a protective antibody response.
